Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This study is being conducted to determine the safety and effect on cognitive function of the
investigational medication, EVP-6124, in individuals with mild to moderate probable
Alzheimer's disease.